Monday, November 22, 2010

Arimidex vs. Tamoxifen

Arimidex (generic name, anastrozole) was FDA approved in 1996 to treat advanced (metastatic) breast cancer patients who have not responded well to treatment with the drug, tamoxifen.

Since Tamoxifen is not something I will be taking ;{ it might make sense to look into this. I have a feeling that there's going to be an argument that node involvement -- even with clear CT, PET, and bone scans -- could fall somewhere between the "little cells" brokering of fear and metastasis.

However, since side effects are gastro, means that it is particularly hard on that system.

No comments:

Post a Comment